Menu Close

Articles on Patents

Displaying 1 - 20 of 111 articles

Getty Images

Patently insufficient: a new intellectual property treaty does little to protect Māori traditional knowledge

The newly signed global Treaty on Intellectual Property, Genetic Resources and Traditional Knowledge might improve the patent system, but is unlikely to improve protection of Indigenous knowledge itself.
Government information sources like the U.S. patent database often file bad information without labeling it or providing a way to retract it. Thinglass/iStock via Getty Images

When authoritative sources hold onto bad data: A legal scholar explains the need for government databases to retract information

Theranos was dissolved years ago, and its CEO, Elizabeth Holmes, is in prison, but the company’s patents based on bad science live on – a stark example of the persistence of faulty information.
A virology lab researcher works to develop a test that will detect the P.1 variant of the coronavirus, in São Paulo, Brazil, in March 2021. (AP Photo/Andre Penner)

Why we need open-source science innovation — not patents and paywalls

In open-source endowed research positions, professors release all of their intellectual property. Surveys of academics in the U.S. and Canada find most like the idea.
Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP. Andrii Zastrozhnov/iStock via Getty Images Plus

Pharma’s expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Global Justice campaigners in London stand by fake coffins to highlight global COVID-19 deaths. If pharma companies waived intellectual property rights, it would be easier for low- and middle-income countries to access COVID-19 vaccines. (AP Photo/Alastair Grant)

We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting

Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
From thalidomide to Viagra, drug repurposing salvaged failed treatments by giving them new targets. smartboy10/DigitalVision Vectors via Getty Images

Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier

Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.

Top contributors

More